Apple Watch models seem to have hit a plateau in their development, as challenges with adding new features persist for Apple. Even the anticipated Apple Watch Series 10, which was expected to include blood pressure monitoring, only offered a size upgrade. The focus has shifted away from the manufacturing process for chipsets, leading to unchanged battery life. Recent reports indicate these factors have contributed to a 19% decline in Apple Watch shipments in Q4 2024.
The dip in demand in the U.S. plays a significant role in this decline, with newer models lacking innovative features that could have boosted interest. Notably, the North American market accounts for over half of the shipments, and this is the second straight year to see a decrease. According to Balbir Singh, the absence of a new, affordable Apple Watch SE, coupled with minimal upgrades in the Apple Watch Series 10 and no introduction of a new Apple Watch Ultra model, are key reasons behind this trend.
Despite these challenges, there is potential for a rebound if Apple releases updated versions of the Apple Watch SE and Apple Watch Ultra 3. However, the company is facing hurdles with these projects. For instance, there’s an effort to reduce costs for the Apple Watch SE by using an all-plastic chassis, a decision that hasn’t been well-received internally.
Additionally, the integration of a non-invasive blood glucose monitoring sensor could significantly drive shipments. Unfortunately, this feature is still years away from being incorporated into future models. There were reports of an Apple Watch Series 10 prototype featuring a mysterious sensor that didn’t make it to production, leaving its purpose uncertain.
Overall, while Apple faces current challenges, strategic upgrades and innovations could pave the way for renewed interest and growth in the Apple Watch market.
